Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group
© Reinacher-Schick et al.; licensee BioMed Central Ltd. 2012
Received: 18 September 2011
Accepted: 26 June 2012
Published: 9 August 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|18 Sep 2011||Submitted||Original manuscript|
|16 Oct 2011||Reviewed||Reviewer Report - Susan Richman|
|2 Nov 2011||Reviewed||Reviewer Report - Frederic Bibeau|
|4 Nov 2011||Reviewed||Reviewer Report - katia bencardino|
|25 Feb 2012||Author responded||Author comments - Anke Reinacher-Schick|
|Resubmission - Version 2|
|25 Feb 2012||Submitted||Manuscript version 2|
|6 Mar 2012||Reviewed||Reviewer Report - Susan Richman|
|13 Mar 2012||Reviewed||Reviewer Report - katia bencardino|
|11 Apr 2012||Reviewed||Reviewer Report - Frederic Bibeau|
|23 Apr 2012||Author responded||Author comments - Anke Reinacher-Schick|
|Resubmission - Version 3|
|23 Apr 2012||Submitted||Manuscript version 3|
|8 May 2012||Reviewed||Reviewer Report - Susan Richman|
|15 Jun 2012||Author responded||Author comments - Anke Reinacher-Schick|
|Resubmission - Version 4|
|15 Jun 2012||Submitted||Manuscript version 4|
|26 Jun 2012||Editorially accepted|
|9 Aug 2012||Article published||10.1186/1471-2407-12-349|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.